What is he best known for?
The fields of study he is best known for:
- Optics
- Immune system
- Laser
Immunology, Tuberculosis, Mycobacterium tuberculosis, Virology and Antigen are his primary areas of study.
Peter Andersen usually deals with Immunology and limits it to topics linked to Tuberculosis vaccines and Clinical trial.
His research in Tuberculosis intersects with topics in T cell and Protein subunit.
His Mycobacterium tuberculosis research includes elements of Proteome, Disease and Microbiology.
Peter Andersen studied Virology and Immunity that intersect with Booster dose and Dimethyldioctadecylammonium bromide.
His biological study spans a wide range of topics, including Interferon gamma and Fusion protein.
His most cited work include:
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. (1125 citations)
- Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. (354 citations)
- Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells (318 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Immunology, Optics, Tuberculosis, Antigen and Virology.
His research ties Tuberculosis vaccines and Immunology together.
His Tuberculosis study frequently draws connections to other fields, such as Interferon gamma.
His Antigen research is multidisciplinary, relying on both T cell, Molecular biology and Microbiology.
He works mostly in the field of Virology, limiting it down to topics relating to Cytotoxic T cell and, in certain cases, CD8, as a part of the same area of interest.
His Adjuvant research integrates issues from Liposome and Immunogenicity.
He most often published in these fields:
- Immunology (32.26%)
- Optics (27.06%)
- Tuberculosis (26.91%)
What were the highlights of his more recent work (between 2016-2021)?
- Immunology (32.26%)
- Antigen (26.61%)
- Tuberculosis (26.91%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Immunology, Antigen, Tuberculosis, Adjuvant and Immune system.
His biological study focuses on Cellular immunity.
His work in the fields of Mycobacterium tuberculosis, Active tb and Tuberculin overlaps with other areas such as In patient.
His Adjuvant research focuses on Pharmacology and how it connects with CTL*.
His work carried out in the field of Immune system brings together such families of science as Virology, Nasal administration, Cytokine and Drug delivery.
The concepts of his Virology study are interwoven with issues in Epitope, Antibody, Chronic infection and In vivo.
Between 2016 and 2021, his most popular works were:
- Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination (244 citations)
- Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis (83 citations)
- Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis -infected lung (68 citations)
In his most recent research, the most cited papers focused on:
- Optics
- Immune system
- Laser
His main research concerns Immunology, Tuberculosis, Adjuvant, Antigen and Mycobacterium tuberculosis.
His work on Parenchyma expands to the thematically related Immunology.
Peter Andersen is interested in Tuberculin, which is a branch of Tuberculosis.
His studies deal with areas such as Cytotoxic T cell, CD8, Immunogenicity and Virology as well as Adjuvant.
His research in Antigen intersects with topics in QuantiFERON, Serology, Outpatient clinic and Confidence interval.
His Vaccination research incorporates elements of Tuberculosis vaccines, Seroconversion, ESAT-6 and Immunization.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
